Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients

Humanitas and Gavazzeni / Castelli COVID-19 Task Forces

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients'. Together they form a unique fingerprint.

Medicine & Life Sciences